A non-parametric propensity score for estimating the effect of interferon-beta or glatiramer acetate on long-term outcomes of multiple sclerosis.

Multiple Sclerosis and Related Disorders
Miceline MésidorPierre Duquette

Abstract

The few observational studies that investigated the long-term effects of interferon-beta and glatiramer acetate were usually focused on progression to irreversible disability and other outcomes such as number of relapses and transition to secondary-progressive multiple sclerosis (SPMS) have been rarely studied. The objective of this paper is to estimate the effect of interferon-beta/glatiramer acetate on progression to irreversible disability, transition from relapsing-remitting multiple sclerosis (RRMS) to SPMS and the rate of relapses over 10 years. Analyses included 2498 patients with confirmed diagnosis of RRMS followed in Montréal from 1977 to 2016. Marginal structural models with propensity score for treatment and censoring were used to account for potential confounding and attrition. Specifically, we used pooled logistic regression for progression to irreversible disability and transition to SPMS, and Poisson models for the rate of relapses. 77% of subjects were female and the median age at RRMS diagnosis was 35 years. The hazard of progression to irreversible disability was lower among treated patients than untreated patients (HR=0.73, 95% CI [0.57-0.94]). We did not find evidence of an association between interferon-be...Continue Reading

References

Mar 5, 2003·Brain : a Journal of Neurology·Christian ConfavreuxPatrice Adeleine
Jun 23, 2006·Journal of Epidemiology and Community Health·Miguel A Hernán, James M Robins
Jul 13, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M PugliattiI Milanov
Apr 21, 2007·Annals of Neurology·Maria TrojanoMaria Pia Amato
Jul 22, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M DebouverieUNKNOWN LORSEP Group
Aug 7, 2008·American Journal of Epidemiology·Stephen R Cole, Miguel A Hernán
Dec 4, 2009·Nephron. Clinical Practice·Diana C GrootendorstFriedo W Dekker
Apr 29, 2010·Brain : a Journal of Neurology·Emmanuelle LerayGilles Edan
Apr 19, 2011·International Journal of Methods in Psychiatric Research·Melissa J AzurPhilip J Leaf
Nov 19, 2011·Statistics in Medicine·Michal AbrahamowiczMarie-Pierre Sylvestre
Dec 6, 2011·PloS One·Douglas S GoodinUNKNOWN 16-Year Long-Term Follow-up Study Investigators
Jun 2, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Roberto BergamaschiMaria Trojano
Jul 17, 2012·JAMA : the Journal of the American Medical Association·Afsaneh ShiraniHelen Tremlett
Nov 6, 2012·Multiple Sclerosis : Clinical and Laboratory Research·H TedeholmO Andersen
Jan 1, 2014·Clinical Neurology and Neurosurgery·Jelena DrulovicTatjana Pekmezovic
Feb 4, 2014·Mayo Clinic Proceedings·Dean M Wingerchuk, Jonathan L Carter
Aug 7, 2014·European Neurology·Christian P KammChris H Polman
Apr 8, 2015·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T ZhangUNKNOWN BC MS Clinic Neurologists
Jun 19, 2015·Brain and Behavior·Guillermo IzquierdoAntonio José García-Ruiz
Sep 17, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Ludwig KapposBernard M J Uitdehaag
Jul 13, 2016·Brain : a Journal of Neurology·Johannes LorscheiderUNKNOWN MSBase Study Group
Feb 18, 2017·Neurology. Neuroimmunology and Neuroinflammation·Mat D DavisVolker Knappertz
Dec 30, 2017·Pharmacoepidemiology and Drug Safety·Laura PazzagliShahram Bahmanyar
Jan 16, 2019·JAMA : the Journal of the American Medical Association·J William L BrownUNKNOWN MSBase Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.